The  	The  	 DT	O
science  	science  	 NN	O
and  	and  	 CC	O
practice  	practice  	 NN	O
of  	of  	 IN	O
bone  	bone  	 NN	O
health  	health  	 NN	O
in  	in  	 IN	O
oncology 	oncology 	 NNS	B-NP
:  	:  	 :	O
managing  	managing  	 VBG	B-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
and  	and  	 CC	O
metastasis  	metastasis  	 NN	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
solid  	solid  	 JJ	O
tumors  	tumors  	 JJ	O
Cancer  	Cancer  	 NNP	O
and  	and  	 CC	O
its  	its  	 PRP$	O
treatment  	treatment  	 NN	O
can  	can  	 MD	O
compromise  	compromise  	 VB	O
bone  	bone  	 JJ	O
health 	health 	 NN	O
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
fracture 	fracture 	 VB	O
,  	,  	 ,	O
pain 	pain 	 NN	O
,  	,  	 ,	O
loss  	loss  	 NN	O
of  	of  	 IN	O
mobility 	mobility 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
hypercalcemia  	hypercalcemia  	 NN	B-NP
of  	of  	 IN	I-NP
malignancy 	malignancy 	 NN	I-NP
.  	.  	 .	O
Bone  	Bone  	 JJ	B-NP
metastasis  	metastasis  	 NN	I-NP
occurs  	occurs  	 VBZ	O
frequently  	frequently  	 RB	O
in  	in  	 IN	O
advanced  	advanced  	 JJ	O
prostate  	prostate  	 NN	B-NP
and  	and  	 CC	O
breast  	breast  	 JJ	O
cancers 	cancers 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
bony  	bony  	 JJ	O
manifestations  	manifestations  	 NNS	B-NP
are  	are  	 VBP	O
commonplace  	commonplace  	 VBN	O
in  	in  	 IN	O
multiple  	multiple  	 JJ	O
myeloma 	myeloma 	 NN	B-NP
.  	.  	 .	O
Osteoporosis  	Osteoporosis  	 NNP	B-NP
and  	and  	 CC	O
osteopenia  	osteopenia  	 NNS	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
consequences  	consequences  	 NNS	B-NP
of  	of  	 IN	I-NP
androgen-deprivation  	androgen-deprivation  	 JJ	I-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	I-NP
prostate  	prostate  	 JJ	I-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
aromatase  	aromatase  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
for  	for  	 IN	O
breast  	breast  	 JJ	O
cancer 	cancer 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
chemotherapy-induced  	chemotherapy-induced  	 JJ	O
ovarian  	ovarian  	 JJ	B-NP
failure 	failure 	 NN	I-NP
.  	.  	 .	O
Osteoporotic  	Osteoporotic  	 JJ	B-NP
bone  	bone  	 NN	I-NP
loss  	loss  	 NN	I-NP
and  	and  	 CC	O
bone  	bone  	 NN	O
metastasis  	metastasis  	 VBZ	O
ultimately  	ultimately  	 RB	O
share  	share  	 VB	O
a  	a  	 DT	O
pathophysiologic  	pathophysiologic  	 JJ	B-NP
pathway  	pathway  	 NN	I-NP
that  	that  	 IN	O
stimulates  	stimulates  	 JJ	O
bone  	bone  	 NN	B-NP
resorption  	resorption  	 NN	I-NP
by  	by  	 IN	O
increasing  	increasing  	 VBG	O
the  	the  	 DT	O
formation  	formation  	 NN	O
and  	and  	 CC	O
activity  	activity  	 NN	O
of  	of  	 IN	O
osteoclasts 	osteoclasts 	 NN	B-NP
.  	.  	 .	O
Important  	Important  	 JJ	B-NP
mediators  	mediators  	 NNS	I-NP
of  	of  	 IN	I-NP
pathologic  	pathologic  	 JJ	I-NP
bone  	bone  	 NN	I-NP
metabolism  	metabolism  	 NNS	I-NP
include  	include  	 VBP	O
substances  	substances  	 VBN	O
produced  	produced  	 VBN	O
by  	by  	 IN	O
osteoblasts 	osteoblasts 	 NN	B-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
RANKL 	RANKL 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
activator  	activator  	 NN	I-NP
of  	of  	 IN	O
nuclear  	nuclear  	 JJ	O
factor  	factor  	 NN	B-NP
kappa  	kappa  	 NN	I-NP
B  	B  	 NN	I-NP
ligand 	ligand 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
spurs  	spurs  	 VBZ	O
osteoclast  	osteoclast  	 JJ	B-NP
differentiation  	differentiation  	 NN	I-NP
from  	from  	 IN	O
myeloid  	myeloid  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Available  	Available  	 JJ	B-NP
therapies  	therapies  	 NNS	I-NP
are  	are  	 VBP	O
targeted  	targeted  	 VBN	O
to  	to  	 TO	O
various  	various  	 JJ	O
steps  	steps  	 NNS	O
in  	in  	 IN	O
cascade  	cascade  	 NN	O
of  	of  	 IN	O
bone  	bone  	 NN	B-NP
metastasis 	metastasis 	 NN	I-NP
.  	.  	 .	O
